Dr. Zhang is an assistant research professor at the Department of Surgery, Comprehensive Cancer Center, City of Hope National Medical Center, California, USA. Dr. Zhang worked in the research fields about ischemia-reperfusion damage, cancer angiogenesis, and potential roles of ribonucleotide reductase in carcinogenesis, cancer metastasis, and therapy. Recently, Dr. Zhang has been focusing on genomic and epigenomic alterations in several solid tumors; he is particularly interested in understanding the mechanisms and potential roles of histone methylation and ubiquitination abnormalities in cancer development and targeted therapy of lung cancer. Dr. Zhang has authored about 50 research articles, and he also serves as a reviewer as well as an editorial board member for several peer-reviewed biomedical journals (https://publons.com/researcher/1409290/keqiang-zhang/). He is a member of American Association of Cancer Research (AACR) and Society of Chinese Bioscientists in America (SCBA).